Home › Compare › VYNT vs MCD

VYNT vs MCD: Dividend Comparison 2026

VYNT yields 1030.93% · MCD yields 2.35%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VYNT wins by $24587954.12M in total portfolio value
10 years
VYNT
VYNT
● Live price
1030.93%
Share price
$0.19
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24587954.20M
Annual income
$20,648,027,961,236.51
Full VYNT calculator →
MCD
McDonald's Corporation
● Live price
2.35%
Share price
$308.53
Annual div
$7.26
5Y div CAGR
42.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$78.5K
Annual income
$26,227.70
Full MCD calculator →

Portfolio growth — VYNT vs MCD

📍 VYNT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVYNTMCD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VYNT + MCD cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
VYNT pays
MCD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VYNT
Annual income on $10K today (after 15% tax)
$87,628.87/yr
After 10yr DRIP, annual income (after tax)
$17,550,823,767,051.04/yr
MCD
Annual income on $10K today (after 15% tax)
$200.01/yr
After 10yr DRIP, annual income (after tax)
$22,293.55/yr
At 15% tax rate, VYNT beats the other by $17,550,823,744,757.49/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VYNT + MCD for your $10,000?

VYNT: 50%MCD: 50%
100% MCD50/50100% VYNT
Portfolio after 10yr
$12293977.14M
Annual income
$10,324,013,993,732.10/yr
Blended yield
83.98%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MCD right now

VYNT
Analyst Ratings
1
Hold
Consensus: Hold
Altman Z
-12.0
Piotroski
2/9
MCD
Analyst Ratings
37
Buy
23
Hold
1
Sell
Consensus: Buy
Price Target
$351.76
+14.0% upside vs current
Range: $320.00 — $385.00
Altman Z
4.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VYNT buys
0
MCD buys
0
No recent congressional trades found for VYNT or MCD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVYNTMCD
Forward yield1030.93% ✓2.35%
Annual dividend / share$2.00$7.26 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%42.3% ✓
Portfolio after 10y$24587954.20M ✓$78.5K
Annual income after 10y$20,648,027,961,236.51 ✓$26,227.70
Total dividends collected$24288183.04M ✓$58.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary
Analyst consensusHoldBuy

Year-by-year: VYNT vs MCD ($10,000, DRIP)

YearVYNT PortfolioVYNT Income/yrMCD PortfolioMCD Income/yrGap
1← crossover$113,793$103,092.78$10,815$334.85+$103.0K → VYNT
2$1,218,133$1,096,375.21$11,826$491.71+$1.21M → VYNT
3$12,272,114$10,968,711.02$13,123$730.06+$12.26M → VYNT
4$116,406,425$103,275,262.74$14,853$1,100.07+$116.39M → VYNT
5$1,040,079,657$915,524,782.99$17,257$1,690.61+$1040.06M → VYNT
6$8,757,858,648$7,644,973,414.41$20,752$2,667.01+$8757.84M → VYNT
7$69,533,084,085$60,162,175,331.66$26,103$4,354.83+$69533.06M → VYNT
8$520,809,783,127$446,409,383,156.47$34,794$7,437.78+$520809.75M → VYNT
9$3,682,174,050,693$3,124,907,582,747.50$49,926$13,461.60+$3682174.00M → VYNT
10$24,587,954,195,479$20,648,027,961,236.51$78,550$26,227.70+$24587954.12M → VYNT

VYNT vs MCD: Complete Analysis 2026

VYNT — Stock

Vyant Bio, Inc., a biotechnology company, discovers drugs for complex neurodevelopmental and neurodegenerative disorders. The company's central nervous system (CNS) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning. It focuses on identifying repurposed and novel small molecule clinical candidates for rare CNS genetic disorders including Rett Syndrome (Rett), CDKL5 deficiency disorders (CDD,) and familial Parkinson's disease (PD). Vyant Bio, Inc. has a collaboration agreement to discover drugs for the treatment of Parkinson's Disease. The company is based in Cherry Hill, New Jersey.

Full VYNT Calculator →

MCD — Consumer Discretionary

McDonald's Corporation operates and franchises McDonald's restaurants in the United States and internationally. Its restaurants offer hamburgers and cheeseburgers, chicken sandwiches and nuggets, wraps, fries, salads, oatmeal, shakes, desserts, sundaes, soft serve cones, bakery items, soft drinks, coffee, and beverages and other beverages, as well as breakfast menu, including biscuit and bagel sandwiches, breakfast burritos, hotcakes, and other sandwiches. As of December 31, 2021, the company operated 40,031 restaurants. McDonald's Corporation was founded in 1940 and is headquartered in Chicago, Illinois.

Full MCD Calculator →
📬

Get this VYNT vs MCD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VYNT vs SCHDVYNT vs JEPIVYNT vs OVYNT vs KOVYNT vs MAINVYNT vs YUMVYNT vs QSRVYNT vs SBUX

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.